期刊文献+

系统性红斑狼疮患者的Th2偏移不受CD40/CD154影响

Imbalance toward Th2 predominance in patients with systemic lupus erythematosus did not affected by CD40/CD154
原文传递
导出
摘要 目的探讨系统性红斑狼疮(SLE)患者外周血Th极化状况的改变以及其受CD40/CD154和地塞米松(Dex)的影响。方法使用ELISA法检测SLE患者和对照组血浆IFN-γ和IL-10水平,分离、培养外周血单个核细胞(PBMC),应用CD40 mAb和Dex进行干预,使用ELISA法检测培养液上清IFN-γ和IL-10水平。结果SLE患者血浆IFN-γ水平明显低于对照组(P〈0.01,P〈0.05),活动期组血浆IL-10水平明显高于缓解期组和对照组(均P〈0.01);CD40 mAb对PBMC培养液上清IFN-γ和IL-10水平无影响(均P〉0.05);Dex可使SLE患者PBMC培养液上清IFN-γ水平升高(P〈0.05,P〈0.01),Dex可以明显降低SLE患者和对照组PBMC培养液上清IL-10水平(均P〈0.05)。结论SLE患者血浆IFN-γ水平降低、IL-10水平增高,存在Th2偏移;此种改变不受CD40/CD154影响但能被Dex抑制。 Objective To investigate the polarization of T helper in patients with systemic lupus erythmatosus (SLE) and its changing caused by CD40/CD154 and dexamethasone (Dex). Methods The plasma concentrations of IFN-γ, and IL-10 were measured by ELISA. The cultured PBMCs from patients and healthy control were treated with CD40 mAb or Dex. The supernatant concentrations of IFN-γ, and IL-10 were measured by ELISA. Results The plasma concentration of IFN-γ, in SLE was lower than that in healthy control (P 〈 0.01, P 〈 0.05 ). The plasma concentration of IL-10 in active SLE was higher than that in inactive SLE and healthy control ( all P 〈 0.01 ). The supernatant concentrations of IFN-γ, and IL-10 were not affected by CD40 mAb. Dex could increase the supernatant concentration of IFN-γ, in SLE (P 〈0.05, P 〈0.01 ) and significant decrease IL-10 in three groups ( all P 〈 0.05). Conclusion There were decreased plasma concentration of IFN-γ, and increased IL-10 and Th2 predominance in SLE. This predominance could not be affected by CD40/CD154 but could be affected Dex.
出处 《国际免疫学杂志》 CAS 2008年第1期1-4,共4页 International Journal of Immunology
基金 资金项目:广东省医学科学研究基金资助项目(A2001151),广东省自然科学基金资助项目(04300354)
关键词 红斑狼疮 系统性 极化 TH CD40/CD154 地塞米松 Lupus erythematosus, Systemic Polarization T helper CD40/CD154 Dexamethasone
  • 相关文献

参考文献18

  • 1Wallace DJ , Hahn BH. Dubois' lupus erythematosus. 5 th edition, Baltimore : Williams & Wilkins, 1997, 69-220.
  • 2周广宇,杨永净,毕黎琦(审校).系统性红斑狼疮中T细胞作用的研究进展[J].国外医学(免疫学分册),2005,28(5):274-277. 被引量:6
  • 3李玉杰.共刺激分子CD28:CTLA4/B7及CD40/CD40L和SLE[J].国外医学(免疫学分册),2003,26(3):116-120. 被引量:7
  • 4Masutani K, Akahoshi M, Tsuruya K, et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum, 2001,44(9) : 2097-2106.
  • 5Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25(11) : 1271-1277.
  • 6Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum, 1992, 35(6) : 630-640.
  • 7Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature, 1996, 383 (6603) :787-793.
  • 8Min DJ, Cho ML, Cho CS, et al. Decreased production of interleukin-12 and interferon-gamma is associated with renal involvement in systemic lupus erythematosus. Scand J Rheumatol, 2001, 30(3): 159-163.
  • 9Enghard P, Langnickel D, Riemekasten G. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis. Scand J Rheumatol, 2006, 35(3) : 209-216.
  • 10Chang DM , Su WL, Chu SJ. The expression and significance of intracellular T helper cytokines in systemic lupus erythematosus. Immunol Invest, 2002, 31 ( 1 ) : 1-12.

二级参考文献35

  • 1周广宇,藤尾圭志,俞戎,山本一彦.狼疮模型鼠各脏器中T细胞受体Vβ基因的表达[J].中华风湿病学杂志,2004,8(12):733-736. 被引量:3
  • 2Dorner T, Putterman C. [J].Arthritis Bes,2001,3 (4):197-199.
  • 3Bijl M, Horst G, Limburg PC, et al. [J]. Ann Rheum Dis, 2001,60(5) : 523-526.
  • 4Sharpe AH, Freeman GJ. [J]. Nature Rev Inmmnol, 2002, 2 (2) :116-126.
  • 5Matsui T, Kurokawa M, Kobata T, et al. [J]. J Immunol, 1999,162.(7):4328-4335.
  • 6Chang TT, Kuchroo VK, Sharpe AH. [J]. Curr Dir Autoimmun,2002,5(1) : 113-130.
  • 7Ogawa S, Nitta K, Ham Y, et al. [J]. Kidney International, 2000,58(5) :2215-2220.
  • 8Alegre ML,Frauwirth KA,Thompson CB[J].Nature Rev Immunol,2001,1(3): 220-228.
  • 9Brarra P, Black A, Padlan EA, et al. [ J ]. Int Immunopharmacol,2001, 1(2): 277-294.
  • 10Ishikawa F, Nakano H, Seo A, et al. [J]. Immunology,2002,106(3) :354-362.

共引文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部